Progestin-associated shift of meningioma mutational landscape

Matthieu Peyre(Centre National de la Recherche Scientifique), Michel Kalamarides(Centre National de la Recherche Scientifique), Marine Giry(Centre National de la Recherche Scientifique), Chiara Villa(Centre National de la Recherche Scientifique), C. De Marcellus(Hôpital Ambroise-Paré), Anne‐Laure Boch(Sorbonne Université), Hugues Loiseau(Mayo Clinic), Marc Sanson(Centre National de la Recherche Scientifique), Laure Cazabat(Hôpital Foch), S. Gaillard(Hôpital Foch), Bertrand Baussart(Centre National de la Recherche Scientifique), Marie Laure Raffin‐Sanson(Inserm), Franck Bielle(Centre National de la Recherche Scientifique)
Annals of Oncology
November 29, 2017
10.1093/annonc/mdx763
Cited by 103

Related Papers

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
|The Lancet|2017|401
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
|Nature Genetics|2017|381
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374